Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

RAINFOL-01

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

CVL006-T1002

A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

HLX07Ib/II

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)